Skip to main content

Advertisement

Log in

Sequence Analysis of TNFRSF13b, Encoding TACI, in Patients with Systemic Lupus Erythematosus

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

B cell activating factor belonging to the TNF family (BAFF) and a proliferation inducing ligand (APRIL), and their receptors BAFF receptor (BAFFR), B cell maturation antigen (BCMA), and transmembrane activator and CAML interactor (TACI) are involved in the regulation of B cell homeostasis and differentiation. BAFF overexpression leads to systemic lupus erythematosus (SLE) in mice and elevated BAFF levels have been observed in human SLE and mouse models for SLE. Furthermore, genetic inactivation of TACI in mice results in a SLE-like phenotype. Based on our recent finding that TACI is mutated in patients with common variable immunodeficiency, of whom more than 30% suffer from autoimmune conditions, we analyzed TACI in humans with SLE. Sequence analysis of TNFRSF13b/TACI in 119 unrelated SLE patients revealed four variants: R20C in exon 1, R72H in exon 3, the silent variation c.327 G > A in exon 3, and A181E in exon 4. No significant association with any of these variants was found, when compared to the frequencies of the variants in a healthy control cohort. Furthermore, the mutated alleles R20C and R72H did not segregate with the SLE phenotype in familial cases of SLE. Thus, our evaluation of the coding region of TNFRSF13b/TACI did not reveal any deleterious or disease-associated mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

REFERENCES

  1. Stohl W: BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists. Curr Dir Autoimmun 8:289–304, 2005

    Article  PubMed  CAS  Google Scholar 

  2. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697–1710, 1999

    Article  PubMed  CAS  Google Scholar 

  3. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995–999, 2000

    Article  PubMed  CAS  Google Scholar 

  4. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, Bastian H, Kimberly RP, Zhou T: Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166:6–10, 2001

    PubMed  CAS  Google Scholar 

  5. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F: Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109:59–68, 2002

    Article  PubMed  CAS  Google Scholar 

  6. Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM: BLyS and APRIL in rheumatoid arthritis. J Clin Invest 115:3083–3092, 2005

    Article  PubMed  CAS  Google Scholar 

  7. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Roschke V, Wu Y, Baker KP, Hilbert DM: Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 63:1096–1103, 2004

    Article  PubMed  CAS  Google Scholar 

  8. Stein JV, Lopez-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodriguez D, Gomez-Caro R, De Jong J, Martinez-A C, Medema JP, Hahne M: APRIL modulates B and T cell immunity. J Clin Invest 109:1587–1598, 2002

    Article  PubMed  CAS  Google Scholar 

  9. Koyama T, Tsukamoto H, Masumoto K, Himeji D, Hayashi K, Harada M, Horiuchi T: A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology (Oxford) 42:980–985, 2003

    Article  CAS  Google Scholar 

  10. Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS: Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18:279–288, 2003

    Article  PubMed  CAS  Google Scholar 

  11. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37:820–828, 2005

    Article  PubMed  CAS  Google Scholar 

  12. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37:829–834, 2005

    Article  PubMed  CAS  Google Scholar 

  13. Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48, 1999

    Article  PubMed  CAS  Google Scholar 

  14. Rankin EC, Isenberg DA: IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus 6:390–394, 1997

    PubMed  CAS  Google Scholar 

  15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277, 1982

    Article  PubMed  CAS  Google Scholar 

  16. Melchers I, Buchegger-Podbielski U, Feldmeyer A, Lodemann P: Family collections for the analysis of common autoimmune disease genes in systemic rheumatic and inflammatory diseases. Arthritis Res 4(Suppl. 1):21, 2002

    Article  Google Scholar 

  17. Ng PC, Henikoff S: Predicting deleterious amino acid substitutions. Genome Res 11:863–874, 2001

    Article  PubMed  CAS  Google Scholar 

  18. Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 30:3894–3900, 2002

    Article  PubMed  CAS  Google Scholar 

  19. Pan-Hammarström Q, Salzer U, Du L, Björkander J, Cunningham-Rundles C, Nelson DL, Bacchelli C, Gaspar HB, Offer S, Behrens TW, Grimbacher B, Hammarström L: Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; in press

  20. Hymowitz SG, Patel DR, Wallweber HJ, Runyon S, Yan M, Yin J, Shriver SK, Gordon NC, Pan B, Skelton NJ, Kelley RF, Starovasnik MA: Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280:7218–7227, 2005

    Article  PubMed  CAS  Google Scholar 

  21. Inoue K, Mineharu Y, Inoue S, Yamada S, Matsuda F, Nozaki K, Takenaka K, Hashimoto N, Koizumi A: Search on chromosome 17 centromere reveals TNFRSF13B as a susceptibility gene for intracranial aneurysm: a preliminary study. Circulation 113:2002–2010, 2006

    Article  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENTS

We are indebted to Dr. Pascal Schneider for providing us with the Flag-ACRP-hAPRIL construct. Grant support: Deutsche Forschungsgemeinschaft SFB620/C2; EU SP23-CT-2005-006411; NIH/NIAID: USIDnet grant # NO1-A1-30070 (B. G.), BMBF KN Rheuma C2.12 (T.W. and R.E.S) and the German Federal Ministry of Education and Research, Competence Network Rheumatism 01 GI 9949/C2.13 (I. M.). C.B. and S.B. are supported by the Primary Immunodeficiency Association (PIA) and the Medical Research Council (MRC), UK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bodo Grimbacher.

Additional information

Inga Melchers and Bodo Grimbacher contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salzer, U., Birmelin, J., Bacchelli, C. et al. Sequence Analysis of TNFRSF13b, Encoding TACI, in Patients with Systemic Lupus Erythematosus. J Clin Immunol 27, 372–377 (2007). https://doi.org/10.1007/s10875-007-9094-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-007-9094-y

KEY WORDS

Navigation